Phase II study of panitumumab monotherapy in chemotherapy-naïve frail or elderly patients with unresectable, RAS wild-type colorectal cancer: OGSG 1602.

Authors

null

Katsuya Ohta

Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan

Katsuya Ohta , Takeshi Kato , Masahiro Goto , Tetsuji Terazawa , Shingo Noura , Hironaga Satake , Yoshinori Kagawa , Hisato Kawakami , Hiroko Hasegawa , Kazuhiro Yanagihara , Tatsushi Shingai , Ken Nakata , Masahito Kotaka , Masayuki Hiraki , Ken Konishi , Shiro Nakae , Daisuke Sakai , Yukinori Kurokawa , Toshio Shimokawa , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Anal and Colorectal Cancer

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

UMIN000024528

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 106)

Abstract #

106

Poster Bd #

E14

Abstract Disclosures